Kangji Medical Holdings Limited (FRA:50J)

Kangji Medical Holdings Statistics

Total Valuation

FRA:50J has a market cap or net worth of EUR 1.17 billion. The enterprise value is 958.88 million.

Market Cap	1.17B
Enterprise Value	958.88M

Important Dates

The last earnings date was Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 27, 2025

Share Statistics

Current Share Class	1.21B
Shares Outstanding	n/a
Shares Change (YoY)	+0.68%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	351.80M

Valuation Ratios

The trailing PE ratio is 17.56.

PE Ratio	17.56
Forward PE	n/a
PS Ratio	9.41
PB Ratio	3.80
P/TBV Ratio	3.80
P/FCF Ratio	20.30
P/OCF Ratio	18.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.66, with an EV/FCF ratio of 16.62.

EV / Earnings	14.37
EV / Sales	7.63
EV / EBITDA	13.66
EV / EBIT	14.37
EV / FCF	16.62

Financial Position

The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.00.

Current Ratio	5.14
Quick Ratio	4.84
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.00
Interest Coverage	8,693.87

Financial Efficiency

Return on equity (ROE) is 22.65% and return on invested capital (ROIC) is 14.88%.

Return on Equity (ROE)	22.65%
Return on Assets (ROA)	9.96%
Return on Invested Capital (ROIC)	14.88%
Return on Capital Employed (ROCE)	22.63%
Revenue Per Employee	117,155
Profits Per Employee	62,828
Employee Count	1,007
Asset Turnover	0.28
Inventory Turnover	1.89

Taxes

In the past 12 months, FRA:50J has paid 14.34 million in taxes.

Income Tax	14.34M
Effective Tax Rate	17.69%

Stock Price Statistics

The stock price has increased by +54.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+54.10%
50-Day Moving Average	0.91
200-Day Moving Average	0.83
Relative Strength Index (RSI)	60.67
Average Volume (20 Days)	17

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:50J had revenue of EUR 124.42 million and earned 66.72 million in profits. Earnings per share was 0.06.

Revenue	124.42M
Gross Profit	98.29M
Operating Income	70.27M
Pretax Income	81.06M
Net Income	66.72M
EBITDA	73.43M
EBIT	70.27M
Earnings Per Share (EPS)	0.06

Balance Sheet

The company has 210.47 million in cash and 109,471 in debt, giving a net cash position of 210.36 million.

Cash & Cash Equivalents	210.47M
Total Debt	109,471
Net Cash	210.36M
Net Cash Per Share	n/a
Equity (Book Value)	308.37M
Book Value Per Share	0.26
Working Capital	218.08M

Cash Flow

In the last 12 months, operating cash flow was 63.90 million and capital expenditures -6.20 million, giving a free cash flow of 57.70 million.

Operating Cash Flow	63.90M
Capital Expenditures	-6.20M
Free Cash Flow	57.70M
FCF Per Share	n/a

Margins

Gross margin is 79.00%, with operating and profit margins of 56.48% and 53.63%.

Gross Margin	79.00%
Operating Margin	56.48%
Pretax Margin	65.15%
Profit Margin	53.63%
EBITDA Margin	59.02%
EBIT Margin	56.48%
FCF Margin	46.37%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.22%.

Dividend Per Share	0.03
Dividend Yield	3.22%
Dividend Growth (YoY)	-83.82%
Years of Dividend Growth	4
Payout Ratio	293.46%
Buyback Yield	-0.68%
Shareholder Yield	2.54%
Earnings Yield	5.70%
FCF Yield	4.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5